Upon patient record review, 1 of 5 (Patient #3) did not have evidence in the patient record that a review was completed of all prescription and non-prescription medications, including herbal remedies that could affect drug therapy. This review includes, but is not limited to: • Effectiveness of drug therapy • Drug side effects • Actual or potential drug interactions • Duplicate drug therapy • Drug therapy currently associated with laboratory monitoring Patient 3: During home visit a bottle of Nifedipine ER 30mg with the patients name on it was found with his listed daily medications. Per patient, he is currently taking Nifedipine ER 30mg by mouth daily. Nifedipine was not included on the medication profile for the hospice.
Every finding on record at Panakeia Hospice, Inc.
Valley Village, California · CCN B51719
2 findings across 1 survey, in the inspector's own words.
The inspector’s own words from form CMS-2567, unedited, including CMS’s own spacing. Names and some dates are redacted by CMS.
Survey of June 6, 2023
2 findingsUpon patient record review, 1 of 5 (Patient #3) did not have evidence the plan of care must include all services necessary for the palliation and management of the terminal illness and related conditions, including medications and treatments. Patient 3: During home visit a bottle of Nifedipine ER 30mg with the patients name on it was found with his listed daily medications. Per patient, he is currently taking Nifedipine ER 30mg by mouth daily. Patient has been taking this medication since March 24th, 2023. No evidence of an order for Nifedipine.
← Back to the Panakeia Hospice, Inc. record
Federal survey findings only. State licensure findings for hospices are not shown.
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction